Investing

Top Rated Halal Stocks to Buy in 2025

Zoya Team

• 6 min read
Top Rated Halal Stocks to Buy in 2025

Finding stocks that align with both strong financial performance and Shariah compliance can feel limiting. Many of the world’s most valuable companies fail to meet Islamic investment criteria due to their involvement in interest-based finance, impermissible business lines, or controversial activities. But there’s still a sizable universe of companies that not only pass Shariah compliance, but also carry high conviction from analysts.

This list highlights those names. We started with the largest companies by market capitalization, filtered for those with Buy or Strong Buy ratings, and then screened for Shariah compliance. The result: a shortlist of top-performing halal stocks worth considering in 2025.

1. Apple (AAPL)

  • Sector: Technology
  • Rating: Buy
  • Shariah Compliance: ✅

Apple leads in consumer technology with a diversified revenue base across iPhones, Macs, iPads, services, and wearables. The services segment, which includes iCloud, App Store fees, and Apple Music, now accounts for over 20% of total revenue and continues to grow rapidly. This growth, while positive from a financial standpoint, does raise some concerns from a Shariah compliance perspective—particularly around Apple Music and Apple TV content. It's something to monitor as the services segment becomes a larger share of total revenue. The company is also integrating AI features into its product ecosystem, with analysts expecting a major push in the 2025 iOS release. While regulatory scrutiny and supply chain risks remain concerns, Apple’s cash position and customer loyalty make it a long-term defensive play.

2. NVIDIA (NVDA)

  • Sector: Semiconductors
  • Rating: Strong Buy
  • Shariah Compliance: ✅

NVIDIA sits at the center of the generative AI boom, with its GPUs powering everything from ChatGPT training runs to enterprise inference deployments. In its most recent earnings report, data center revenue more than doubled year-over-year. The upcoming Blackwell GPU architecture, due in late 2025, is expected to further solidify its lead. Risks include supply constraints and potential export restrictions, but overall demand remains strong across hyperscalers and sovereign AI initiatives.

3. Broadcom (AVGO)

  • Sector: Semiconductors / Infrastructure Software
  • Rating: Strong Buy
  • Shariah Compliance: ✅

Broadcom generates revenue from both hardware—like RF chips and custom silicon—and recurring software via VMware and Symantec enterprise products. Its $69 billion acquisition of VMware was completed in 2023 and is already contributing to margin expansion. The company’s ability to cross-sell software into its telecom and cloud hardware customer base is a unique strength. With strong free cash flow and aggressive share buybacks, Broadcom remains a favorite among value-oriented growth investors.

4. Taiwan Semiconductor (TSM)

  • Sector: Semiconductors
  • Rating: Buy
  • Shariah Compliance: ✅

TSMC is the world’s most advanced chip foundry, producing chips for Apple, AMD, NVIDIA, and Qualcomm. It recently began ramping 3nm production and is investing heavily in 2nm and U.S.-based fabs. Although geopolitical tensions in Taiwan pose headline risk, TSMC’s strategic importance has led to diversified capacity in Japan and Arizona. Gross margins are above 50%, and management continues to forecast double-digit revenue growth over the next several years.

5. Eli Lilly and Co. (LLY)

  • Sector: Healthcare
  • Rating: Buy
  • Shariah Compliance: ✅

Eli Lilly is a global pharmaceutical leader, best known for its advancements in diabetes and obesity management. Its GLP-1 drug Mounjaro has seen explosive demand and is widely seen as a potential blockbuster for weight loss. The company also has a deep pipeline in Alzheimer’s disease, oncology, and immunology. With a robust R&D budget and expanding production capacity, analysts see continued upside, although some caution around valuation has emerged after its rapid stock appreciation.

6. Visa (V)

  • Sector: Financial Services / Payments
  • Rating: Buy
  • Shariah Compliance: ✅

Visa is the largest global card network, enabling over $15 trillion in annual payment volume. It earns revenue through transaction fees and data processing—not by lending or charging interest. Its cross-border volumes have rebounded post-COVID, and recent partnerships with fintechs and embedded finance players have helped it stay relevant.

7. Mastercard (MA)

  • Sector: Financial Services / Payments
  • Rating: Buy
  • Shariah Compliance: ✅

Mastercard operates the world’s second-largest payments network and continues to expand its footprint through fintech APIs, B2B payment platforms, and tokenized digital wallets. Like Visa, it does not earn interest or extend credit—it monetizes via network fees. Its consistent EPS growth and investments in cybersecurity, AI fraud prevention, and open banking make it a long-term compounder.

8. Oracle (ORCL)

  • Sector: Software / Cloud Infrastructure
  • Rating: Buy
  • Shariah Compliance: ✅

Oracle is a legacy enterprise software giant that’s successfully pivoting to the cloud. Its Oracle Cloud Infrastructure (OCI) is gaining traction as a lower-cost alternative to AWS and Azure, especially among government and healthcare clients. The company also launched a major partnership with NVIDIA in 2024 to bring generative AI training capabilities to its cloud stack. While it still faces competition from hyperscalers, Oracle’s margin profile and customer retention are strong.

9. Home Depot (HD)

  • Sector: Retail / Home Improvement
  • Rating: Buy
  • Shariah Compliance: ✅

Home Depot dominates the U.S. home improvement market, serving both DIY consumers and professional contractors. While housing turnover has slowed due to high interest rates, repair and remodel spending remains resilient. The company has invested in supply chain modernization and pro customer loyalty programs. Despite near-term macro softness, analysts expect long-term demand for aging home renovations and green upgrades to support revenue stability.

10. Procter & Gamble (PG)

  • Sector: Consumer Staples
  • Rating: Buy
  • Shariah Compliance: ✅

P&G owns a portfolio of trusted household brands including Tide, Gillette, Pampers, and Oral-B. Its global distribution, pricing power, and cost discipline have helped the company maintain profitability even during inflationary cycles. Recent innovations in sustainable packaging and premium product lines have helped boost brand loyalty. While growth is modest, its defensive nature and reliable dividends make it a favorite in consumer staples.

11. Johnson & Johnson (JNJ)

  • Sector: Healthcare / Pharmaceuticals
  • Rating: Buy
  • Shariah Compliance: ✅

JNJ’s strength lies in its balance between pharmaceuticals, medtech devices, and consumer health (which it recently spun off into Kenvue). Its cancer drugs, immunology treatments, and surgical products drive consistent earnings. The company has a strong history of dividend growth and continues to invest heavily in research. It’s considered one of the safest blue-chip stocks in healthcare.

12. AbbVie (ABBV)

  • Sector: Healthcare / Biotech
  • Rating: Buy
  • Shariah Compliance: ✅

AbbVie’s diversification beyond Humira has been successful, with Rinvoq and Skyrizi now delivering strong growth. Its acquisition of Allergan added leading brands in aesthetics and neuroscience. The company offers one of the highest dividend yields in large-cap biotech and maintains a solid pipeline in oncology, immunology, and neuroscience. Analysts remain confident in its ability to offset biosimilar pressures.

13. Novo Nordisk (NVO)

  • Sector: Healthcare / Biopharma
  • Rating: Buy
  • Shariah Compliance: ✅

Novo Nordisk is the global leader in diabetes and obesity treatments. Its GLP-1 drugs Ozempic and Wegovy have experienced record-breaking demand. The company is scaling up production and investing in oral formulations to expand its addressable market. With strong margins and growing healthcare budgets worldwide, Novo is viewed as a secular growth story in biopharma.

14. SAP SE (SAP)

  • Sector: Enterprise Software
  • Rating: Strong Buy
  • Shariah Compliance: ✅

SAP is a dominant provider of enterprise resource planning (ERP) software, serving over 400,000 organizations globally. Its cloud migration strategy has accelerated, with a growing share of revenue now recurring. The company is also embedding AI capabilities into core products and expanding in the Middle East and Asia. With strong cash flow and retention rates, it remains a top pick in enterprise tech.

15. Roche (RHHBY)

  • Sector: Biotech / Pharma
  • Rating: Buy
  • Shariah Compliance: ✅

Roche leads in oncology, immunology, and in-vitro diagnostics. Its recent launches include Vabysmo (ophthalmology) and Polivy (lymphoma), adding to a diversified product lineup. The diagnostics division continues to grow, particularly in personalized medicine and molecular testing. Despite currency headwinds, Roche maintains strong cash flow and a defensible pipeline.

16. ASML Holding NV (ASML)

  • Sector: Semiconductors / Lithography
  • Rating: Strong Buy
  • Shariah Compliance: ✅

ASML is the sole provider of EUV lithography machines used in cutting-edge semiconductor manufacturing. Its clients include TSMC, Intel, and Samsung. In 2024, it unveiled its next-gen High-NA EUV system, extending its technological moat. Export restrictions are a risk, but strong backlog and pricing power support its bullish outlook.

17. Abbott (ABT)

  • Sector: Healthcare / Medical Devices
  • Rating: Strong Buy
  • Shariah Compliance: ✅

Abbott spans diagnostics, devices, nutrition, and branded generics. It continues to grow in areas like continuous glucose monitoring with its FreeStyle Libre franchise. The diagnostics business remains stable post-COVID, and structural demand for cardiovascular devices like MitraClip supports growth. Its balance sheet strength and innovation pipeline offer long-term resilience.

18. AstraZeneca (AZN)

  • Sector: Pharmaceuticals
  • Rating: Buy
  • Shariah Compliance: ✅

AstraZeneca is heavily weighted toward oncology, where drugs like Tagrisso and Imfinzi continue to gain share. It also has a growing presence in rare diseases via its Alexion acquisition. Pipeline assets in cell therapy and respiratory medicine show promise. With a strong global footprint and R&D productivity, it remains a key pharma holding.

19. Linde (LIN)

  • Sector: Industrial Gases
  • Rating: Strong Buy
  • Shariah Compliance: ✅

Linde provides oxygen, hydrogen, and specialty gases essential for electronics, healthcare, and clean energy. It’s benefiting from the hydrogen economy buildout, with several long-term supply agreements in place. Its capital discipline, pricing strategy, and strong EBITDA margins make it a favorite among industrial investors.

20. Merck (MRK)

  • Sector: Pharmaceuticals
  • Rating: Buy
  • Shariah Compliance: ✅

Merck’s blockbuster cancer drug Keytruda continues to drive double-digit growth and is approved for over 20 indications. The company is also investing in mRNA vaccines, next-gen antibiotics, and cardiometabolic drugs. With a strong dividend, healthy pipeline, and expanding manufacturing capacity, Merck is positioned for durable performance.

Zoya: Halal Investing App

Zoya makes halal investing easy by helping you build and monitor a Shariah-compliant investment portfolio with confidence and clarity.

Install